Therefore, we aimed to establish a highly sensitive time‐resolved fluorescence immunoassay (TRFIA)14 and evaluate its application for detecting IL‐18 in the serum of liver cancer, hepatitis B, hepatitis C, autoimmune hepatitis, and fatty liver disease patients. The gene discussed is IL18; the disease is fatty liver disease.